Effects of Metformin Versus Glipizide on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Coronary Artery Disease

Original Research

¹Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
²Johns Hopkins University School of Medicine, Baltimore, Maryland
³Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
⁴The Second Xiangya Hospital of Central South University, Changsha, China
⁵Shandong Provincial Hospital, Shandong University, Jinan, China
⁶Chang Hai Hospital, Second Military Medical University, Shanghai, China
⁷The First Affiliated Hospital of Wenzhou Medical College, Zhejiang Province, China
⁸Sir Run Run Shao Hospital, Zhejiang Province, China
⁹Jiangsu Province Hospital, Jiangsu Province, China
¹⁰Shanghai Ten’s People’s Hospital of Tongji University, Shanghai, China
¹¹Nanfang Hospital, Guangdong Province, China
¹²Nanjin Drum Tower Hospital, Jiangsu Province, China

Diabetes Care 2013 May; 36(5): 1304-1311. https://doi.org/10.2337/dc12-0719

Article Figures & Tables

Download figure
Open in new tab
Download powerpoint
Figure 1
SPREAD-DIMCAD trial profile.
Download figure
Open in new tab
Download powerpoint
Figure 2
Changes of major clinical and biochemical characteristics at baseline and during follow-up in different groups. HbA_1c (A), fasting plasma glucose (B), BMI (C), triglycerides (D), total cholesterol (E), LDL cholesterol (F), HDL cholesterol (G), and estimated glomerular filtration rate (eGFR) (H). Data displayed as means ± SD. P value refers to comparison between the groups.